Page 254 - Read Online
P. 254

Aubert et al. Mini-invasive Surg 2019;3:34  I  http://dx.doi.org/10.20517/2574-1225.2019.46                                          Page 3 of 4

                                     [7]
               failure occurred in 15.7% , which is similar or even higher than those reported after laparoscopic TME:
                                                                  [17]
                                      [16]
               13% in the COLOR II trial  and 10% in the CLASSIC trial . The Dutch TaTME registry reported a quite
                                                                                           [18]
               similar rate of anastomotic leak: 16.5% after TaTME vs. 12.2% after laparoscopic TME . Thus, the idea
               that leak rate would be lower after TaTME due to avoiding “dog ear” observed during stapled anastomosis
               performed from above might be wrong, and finally the risk of leak is probably unrelated to the technique
               used for performing TME.

               Long-term functional result in rectal cancer surgery is an important endpoint. Concerning functional
                                       [19]
               results, a comparative study  between TaTME and laparoscopic TME recently reported that functional
               outcomes after TaTME were significantly worse than those after laparoscopic TME. Indeed, anorectal
               symptoms, such as buttock pain (P = 0.011), diarrhea (P = 0.009), clustering of stools (P = 0.017), and
               urgency (P = 0.032), significantly disfavored TaTME, as did the mean low anterior resection syndrome
               score, which is worse after TaTME than laparoscopic TME: 26.18 vs. 20.61 (P = 0.054). These results suggest
               that the use of a transanal device during the entire operating time could lead to a worse functional result,
               which is already altered after standard colo-anal anastomosis.


               To conclude, if TaTME appeared as an attractive alternative for mid and low rectal cancer surgery with
               encouraging results in the first retrospective studies, some concerns have recently emerged, especially
               regarding the oncological results and a higher rate of early and multifocal recurrence, leading the
               Norwegian colorectal cancer group to cease TaTME in their country. Results of ongoing randomized
               control trials are needed to consider or not TaTME as a standard of care in rectal cancer surgery.


               DECLARATIONS
               Authors’ contributions
               Made substantial contributions to conception and design of the study and performed literature review and
               interpretation: Aubert M, Mege D, Panis Y


               Availability of data and materials
               Not applicable.


               Financial support and sponsorship
               None.

               Conflicts of interest
               All authors declared that there are no conflicts of interest.

               Ethical approval and consent to participate
               Not applicable.

               Consent for publication
               Not applicable.

               Copyright
               © The Author(s) 2019.

               REFERENCES
               1.   Sylla P, Rattner DW, Delgado S, Lacy AM. NOTES transanal rectal cancer resection using transanal endoscopic microsurgery and
                   laparoscopic assistance. Surg Endosc 2010;24:1205-10.
               2.   de’Angelis N, Portigliotti L, Azoulay D, Brunetti F. Transanal total mesorectal excision for rectal cancer: a single center experience and
   249   250   251   252   253   254   255   256   257   258   259